Censis Technologies Achieves HITRUST Implemented, 1-year (i1) Certification to Manage Data Protection and Mitigate Cybersecurity Threats

Censis Technologies HITRUST

Censis Technologies, a leading provider of AI-driven surgical instrument tracking technology, proudly announces its CensiTrac and LoanerLink software have earned certified status by HITRUST for information security. HITRUST Implemented, 1-year (i1) Certified status demonstrates Censis’ commitment to deliver a complete security that broadly protects against current and emerging threats.

Helps Organizations Address Cybersecurity Challenges

Through alignment with and incorporation of appropriate security controls, the HITRUST Implemented, 1-year (i1) Validated Assessment with Certification helps organizations address cybersecurity challenges and remain cyber resilient over time.

Poornima Gopalakrishnan, President of Censis Technologies, emphasized…

“HITRUST i1 Certification instills confidence in our internal and external stakeholders, assuring them of our adherence to leading security practices. Upholding robust cybersecurity standards is paramount for minimizing information security risks and safeguarding our organization and business partners. The i1 Certification underscores our ongoing dedication to high standards in cybersecurity and data protection.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”